Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 15c
August 10, 2021 4:22 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.08, $0.15 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.57 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More